# Intas Pharmaceuticals Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8

> Inspection records and compliance data for Intas Pharmaceuticals Limited in Ahmedabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Intas Pharmaceuticals Limited
- FEI Number: 3003157498
- City: Ahmedabad
- State: None
- Country Name: India
- Address Line 1: 218p - Chacharwad, 458 - Matoda; Sarkhej Gandhi Nagar Highway
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [WARNING_LETTER - Intas Pharmaceuticals Limited - 2025-09-17](https://www.globalkeysolutions.net/records/warning_letter/intas-pharmaceuticals-limited/5823afb5-cd04-4920-9a5a-ce851b44651c) — source: FDA, date: September 17, 2025
- [FDA Inspection 1245599 - Intas Pharmaceuticals Limited - 2024-07-12](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/b7786616-f193-421d-81ca-40e09d86547d) — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2024
- [483 - Intas Pharmaceuticals Limited - 2023-05-12](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/f0a0a214-afa3-42a9-8e03-f437d8972141) — source: FDA, date: May 12, 2023
- [483 - Intas Pharmaceuticals Limited - 2023-05-12](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/439bcecd-27da-49d0-b32b-ce7d8d990792) — source: FDA, date: May 12, 2023
- [483 - Intas Pharmaceuticals Limited - 2022-12-02](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/aaef987c-6382-4641-8d0e-9fc48ace87ba) — source: FDA, date: December 2, 2022
- [483 - Intas Pharmaceuticals Limited - 2019-08-02](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/d8b8b922-c242-4064-89d5-38ff992edec5) — source: FDA, date: August 2, 2019
- [FDA Inspection 1098380 - Intas Pharmaceuticals Limited - 2019-08-02](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/0895eb6a-065a-49a6-ac84-da712eda4358) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 2, 2019
- [483 - Intas Pharmaceuticals Limited - 2018-12-14](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/d7d4f9f0-3246-4bd4-b45d-b1149c0a717e) — source: FDA, date: December 14, 2018
- [FDA Inspection 1074349 - Intas Pharmaceuticals Limited - 2018-12-14](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/9fbc901d-b132-4d7d-9fdf-8ac222f2fec6) — classification: No Action Indicated (NAI), source: FDA, date: December 14, 2018
- [483 - Intas Pharmaceuticals Limited - 2018-06-08](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/6c433282-acc9-4639-89b9-e51ca154262e) — source: FDA, date: June 8, 2018
- [FDA Inspection 1056170 - Intas Pharmaceuticals Limited - 2018-06-08](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/40778dca-3416-4505-9b4f-98131521219b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 8, 2018
- [483 - Intas Pharmaceuticals Limited - 2017-07-31](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/4f76e2d8-eaeb-4ac2-a891-807bdf0b6f08) — source: FDA, date: July 31, 2017
- [483 - Intas Pharmaceuticals Limited - 2017-02-17](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-limited/7b1a2fd4-c8a7-4787-b726-6d7bd5f27637) — source: FDA, date: February 17, 2017
- [FDA Inspection 978469 - Intas Pharmaceuticals Limited - 2016-06-17](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/3aaf3f2a-46fc-4904-a72f-b656172dc11e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 17, 2016
- [FDA Inspection 923354 - Intas Pharmaceuticals Limited - 2015-04-07](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/493332f9-a20f-4012-b808-81c974265ac5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 7, 2015
- [FDA Inspection 839384 - Intas Pharmaceuticals Limited - 2013-06-21](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/3256955b-4ca2-4d12-9fa7-e98cbd2bad27) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2013
- [FDA Inspection 788126 - Intas Pharmaceuticals Limited - 2012-05-19](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/41c90e10-2e80-408d-a5b6-f5679faecf3e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2012
- [FDA Inspection 755788 - Intas Pharmaceuticals Limited - 2011-10-10](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/a82b265d-a4b3-4045-9edc-3a8726ce9811) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 10, 2011
- [FDA Inspection 634793 - Intas Pharmaceuticals Limited - 2009-11-13](https://www.globalkeysolutions.net/records/fda_inspections/intas-pharmaceuticals-limited/5fa47b2d-8bab-4582-905b-abb1ef151bf9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 13, 2009

## Related Companies

- [Dr Reddy's Laboratories Limited](https://www.globalkeysolutions.net/companies/dr-reddys-laboratories-limited/97f3d461-62f0-4198-9e9d-7f7c7d43af86)
- [EUGIA Pharma Specialities Limited](https://www.globalkeysolutions.net/companies/eugia-pharma-specialities-limited/7c9f680c-5d29-42a0-a496-02fd4761792b)
- [Mankind Pharma Limited](https://www.globalkeysolutions.net/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777)
- [Evonik Corporation](https://www.globalkeysolutions.net/companies/evonik-corporation/f88f3afa-3508-4fc2-8d70-8558ece37d59)
- [Pharmathen International S.A.](https://www.globalkeysolutions.net/companies/pharmathen-international-sa/4486b3e5-4ce8-40ff-80da-e4364db37198)
- [Catalent Maryland, Inc.](https://www.globalkeysolutions.net/companies/catalent-maryland-inc/b2f722ce-b6bd-42e6-b648-cec5c4b5f44d)
- [Strides Pharma Science Limited](https://www.globalkeysolutions.net/companies/strides-pharma-science-limited/8cbbf469-967b-461a-9ab3-357517269fe2)
- [PharmaGend Global Medical Services Pte. Ltd.](https://www.globalkeysolutions.net/companies/pharmagend-global-medical-services-pte-ltd/a4dcdf70-101c-46bc-94ab-ddb8956f44a4)
- [Stira Pharmaceuticals LLC](https://www.globalkeysolutions.net/companies/stira-pharmaceuticals-llc/5e44f5bb-4d18-40fa-b93c-7510e3099999)
- [Kelix bio (Malta) Ltd.](https://www.globalkeysolutions.net/companies/kelix-bio-malta-ltd/3595e81b-9a31-4dcc-b529-e58034aabdf7)

## Related Officers

- [Pratik S. Upadhyay](https://www.globalkeysolutions.net/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Quality System Specialist](https://www.globalkeysolutions.net/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [ Investigator ](https://www.globalkeysolutions.net/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)